599 related articles for article (PubMed ID: 15508179)
21. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
[TBL] [Abstract][Full Text] [Related]
22. A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-controlled food challenge.
Bolhaar ST; Zuidmeer L; Ma Y; Ferreira F; Bruijnzeel-Koomen CA; Hoffmann-Sommergruber K; van Ree R; Knulst AC
Clin Exp Allergy; 2005 Dec; 35(12):1638-44. PubMed ID: 16393331
[TBL] [Abstract][Full Text] [Related]
23. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study.
Höiby AS; Strand V; Robinson DS; Sager A; Rak S
Clin Exp Allergy; 2010 Jul; 40(7):1062-70. PubMed ID: 20642579
[TBL] [Abstract][Full Text] [Related]
24. Effects of birch pollen SIT on apple allergy: a matter of dosage?
Asero R
Allergy; 2004 Dec; 59(12):1269-71. PubMed ID: 15507094
[No Abstract] [Full Text] [Related]
25. [Oral allergy syndrome due to plant-derived foods: a clinical review of 63 patients over a period of 6 years].
Inomata N; Morita A; Kirino M; Yamazaki H; Yamaguchi J; Yamane Y; Tatewaki S; Hirokado M; Kondo M; Ikezawa Z
Arerugi; 2007 Oct; 56(10):1276-84. PubMed ID: 17982289
[TBL] [Abstract][Full Text] [Related]
26. How long does the effect of birch pollen injection SIT on apple allergy last?
Asero R
Allergy; 2003 May; 58(5):435-8. PubMed ID: 12752332
[TBL] [Abstract][Full Text] [Related]
27. Severe allergy to sharon fruit caused by birch pollen.
Bolhaar ST; van Ree R; Ma Y; Bruijnzeel-Koomen CA; Vieths S; Hoffmann-Sommergruber K; Knulst AC; Zuidmeer L
Int Arch Allergy Immunol; 2005 Jan; 136(1):45-52. PubMed ID: 15591813
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B
J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463
[TBL] [Abstract][Full Text] [Related]
29. Birch pollen immunotherapy inhibits anaphylaxis to the cross-reactive apple allergen Mal d 1 in mice.
Utsch L; Logiantara A; Wallner M; Hofer H; van Ree R; van Rijt LS
Clin Exp Allergy; 2016 Nov; 46(11):1474-1483. PubMed ID: 27376790
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
31. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.
Mauro M; Russello M; Incorvaia C; Gazzola GB; Di Cara G; Frati F
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):119-22. PubMed ID: 17523385
[TBL] [Abstract][Full Text] [Related]
33. Profilin sensitization detected in the office by skin prick test: a study of prevalence and clinical relevance of profilin as a plant food allergen.
Asero R; Monsalve R; Barber D
Clin Exp Allergy; 2008 Jun; 38(6):1033-7. PubMed ID: 18489029
[TBL] [Abstract][Full Text] [Related]
34. Sublingual reactivity to rBET V1 and rPHL P1 in patients with oral allergy syndrome.
Marcucci F; Sensi L; Di Cara G; Gidaro G; Incorvaia C; Frati F
Int J Immunopathol Pharmacol; 2006; 19(1):141-8. PubMed ID: 16569352
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges.
Bolhaar ST; Tiemessen MM; Zuidmeer L; van Leeuwen A; Hoffmann-Sommergruber K; Bruijnzeel-Koomen CA; Taams LS; Knol EF; van Hoffen E; van Ree R; Knulst AC
Clin Exp Allergy; 2004 May; 34(5):761-9. PubMed ID: 15144469
[TBL] [Abstract][Full Text] [Related]
36. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
Panzner P; Petrás M; Sýkora T; Lesná I
Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
[TBL] [Abstract][Full Text] [Related]
37. In vivo assessment with prick-to-prick testing and double-blind, placebo-controlled food challenge of allergenicity of apple cultivars.
Bolhaar ST; van de Weg WE; van Ree R; Gonzalez-Mancebo E; Zuidmeer L; Bruijnzeel-Koomen CA; Fernandez-Rivas M; Jansen J; Hoffmann-Sommergruber K; Knulst AC; Gilissen LJ
J Allergy Clin Immunol; 2005 Nov; 116(5):1080-6. PubMed ID: 16275380
[TBL] [Abstract][Full Text] [Related]
38. Allergy to apple cultivars among patients with birch pollinosis and oral allergy syndrome.
Wagner A; Szwed A; Buczyłko K; Wagner W
Ann Allergy Asthma Immunol; 2016 Oct; 117(4):399-404. PubMed ID: 27593099
[TBL] [Abstract][Full Text] [Related]
39. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy.
Rak S; Heinrich C; Scheynius A
Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810
[TBL] [Abstract][Full Text] [Related]
40. Allergy to kiwi: a double-blind, placebo-controlled food challenge study in patients from a birch-free area.
Alemán A; Sastre J; Quirce S; de las Heras M; Carnés J; Fernández-Caldas E; Pastor C; Blázquez AB; Vivanco F; Cuesta-Herranz J
J Allergy Clin Immunol; 2004 Mar; 113(3):543-50. PubMed ID: 15007359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
